Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  ResMed, Inc.    RMD

RESMED, INC.

(RMD)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

RESMED, INC. : Ex-dividend day for

11/10/2020 EST

A dividend is removed today from ResMed, Inc.'s share.



© Factset 2020
All news about RESMED, INC.
01/13RESMED : 39th Annual J.P. Morgan Healthcare Conference
PU
01/12INSIDER TRENDS : 90-Day Insider Buying Trend at ResMed Slowed with Sale of Share..
MT
01/07RESMED : to Report Second Quarter Fiscal 2021 Earnings on January 28, 2021
BU
01/06RESMED : RMD) sees Significant Insider Sales Extending the Trend of Last Quarter
MT
01/05INSIDER TRENDS : ResMed Insider Disposition Slows 90-Days of Buys
MT
01/05INSIDER TRENDS : Insider Sale Scales Back 90-Day Buy Trend at ResMed
MT
01/05INSIDER TRENDS : ResMed Insider Disposition Interrupting 90-Day Buy Trend
MT
01/05RESMED : Announces Participation in the 39th Annual J.P. Morgan Healthcare Confe..
BU
2020RESMED : Zacks Investment Downgrades ResMed to Neutral From Outperform, Adjusts ..
MT
2020INSIDER TRENDS : 90-Day Insider Buying Trend Reduced with Disposition of ResMed ..
MT
More news
Financials (USD)
Sales 2021 3 142 M - -
Net income 2021 694 M - -
Net Debt 2021 248 M - -
P/E ratio 2021 44,9x
Yield 2021 0,76%
Capitalization 30 667 M 30 667 M -
EV / Sales 2021 9,84x
EV / Sales 2022 8,93x
Nbr of Employees 7 770
Free-Float 77,0%
Chart RESMED, INC.
Duration : Period :
ResMed, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends RESMED, INC.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 10
Average target price 182,86 $
Last Close Price 211,62 $
Spread / Highest target 3,96%
Spread / Average Target -13,6%
Spread / Lowest Target -34,8%
EPS Revisions
Managers and Directors
NameTitle
Michael J. Farrell Chief Executive Officer & Director
Robert Andrew Douglas President & Chief Operating Officer
Peter C. Farrell Non-Executive Chairman
Brett A. Sandercock Chief Financial Officer
Carlos M. Nunez Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
RESMED, INC.-0.44%30 667
THERMO FISHER SCIENTIFIC8.02%199 412
DANAHER CORPORATION6.58%168 182
INTUITIVE SURGICAL, INC.-4.85%91 508
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.3.75%82 922
SIEMENS HEALTHINEERS AG3.86%56 444